Stephens Inc. AR Has $2.67 Million Holdings in Kenvue Inc. $KVUE

Stephens Inc. AR lessened its holdings in shares of Kenvue Inc. (NYSE:KVUE) by 15.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 154,779 shares of the company’s stock after selling 29,261 shares during the quarter. Stephens Inc. AR’s holdings in Kenvue were worth $2,670,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of the business. Allstate Corp bought a new position in shares of Kenvue during the third quarter worth approximately $1,152,000. Aberdeen Group plc boosted its stake in Kenvue by 84.1% in the 3rd quarter. Aberdeen Group plc now owns 1,411,380 shares of the company’s stock valued at $22,914,000 after purchasing an additional 644,930 shares during the period. Oak Thistle LLC acquired a new position in Kenvue in the 4th quarter valued at $1,563,000. Eubel Brady & Suttman Asset Management Inc. grew its holdings in Kenvue by 39.7% in the 3rd quarter. Eubel Brady & Suttman Asset Management Inc. now owns 1,371,886 shares of the company’s stock valued at $22,266,000 after buying an additional 389,704 shares in the last quarter. Finally, Vest Financial LLC increased its position in Kenvue by 4.7% during the 3rd quarter. Vest Financial LLC now owns 2,436,986 shares of the company’s stock worth $39,552,000 after buying an additional 108,480 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

Analyst Ratings Changes

KVUE has been the subject of a number of research reports. Zacks Research raised Kenvue from a “hold” rating to a “strong-buy” rating in a report on Friday, May 8th. Weiss Ratings raised shares of Kenvue from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Canaccord Genuity Group lifted their price objective on shares of Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Citigroup decreased their target price on shares of Kenvue from $20.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 15th. Finally, Barclays dropped their price target on shares of Kenvue from $19.00 to $18.00 and set an “equal weight” rating for the company in a research report on Tuesday, April 14th. One investment analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and twelve have given a Hold rating to the stock. Based on data from MarketBeat, Kenvue presently has a consensus rating of “Hold” and a consensus target price of $19.33.

Insider Activity at Kenvue

In related news, General Counsel Matthew Orlando sold 38,491 shares of the stock in a transaction on Friday, May 8th. The stock was sold at an average price of $17.66, for a total value of $679,751.06. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 1.59% of the company’s stock.

Kenvue Stock Up 0.4%

Shares of KVUE opened at $17.19 on Tuesday. Kenvue Inc. has a 52 week low of $14.02 and a 52 week high of $24.35. The stock has a market capitalization of $33.00 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.30 and a beta of 0.55. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.70 and a current ratio of 0.98. The stock has a fifty day moving average of $17.46 and a 200-day moving average of $17.35.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.05. Kenvue had a return on equity of 20.81% and a net margin of 10.61%.The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $3.84 billion. During the same period in the prior year, the company earned $0.24 EPS. Kenvue’s revenue was up 4.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that Kenvue Inc. will post 1.16 earnings per share for the current fiscal year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 27th. Stockholders of record on Wednesday, May 13th will be paid a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.8%. The ex-dividend date is Wednesday, May 13th. Kenvue’s dividend payout ratio is presently 97.65%.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over?the?counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.